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CASE REPORT
DISSEMINATED TOXOPLASMOSIS IN AN IMMUNOCOMPETENT PATIENT FROM PERUVIAN AMAZON
Juan NUNURA(1), Tania VÁSQUEZ(2), Sergio ENDO(2), Daniela SALAZAR(2), Alejandrina RODRIGUEZ(2), Sonia PEREYRA(3) & HILDA SOLIS(4)
SUMMARY
We report a case of severe toxoplasmosis in an immunocompetent patient, characterized by pneumonia, retinochoroiditis, hepatitis 
and myositis. Diagnosis was confirmed by serology, T. gondii in thick blood smear and presence of bradyzoites in muscle biopsy. 
Treatment with pyrimethamine plus sulfadoxine was successful but visual acuity and hip extension were partially recovered. This is 
the first case report of severe toxoplasmosis in an immunocompetent patient from Peru.
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INTRODUCTION
Toxoplasmosis has decreased in the last decades due to a greater 
control of its transmission patterns37. However, it is still common in 
tropical regions like the Amazon. In India, 2% of the population is 
seropositive, whereas in Brazil seroprevalence ranges from 65.8% to 
75%. By the 1980s, 84% of the people in the Peruvian Amazon were 
seropositive2,16,26,28. 
T. gondii infection varies according to the patient’s immune status. 
It is mostly asymptomatic among inmunocompetent patients. Clinical 
manifestations such as pneumonia myocarditis, hepatitis and encephalitis 
are rarely reported. On the contrary, life threatening encephalitis, 
pneumonitis and multiorgan involvement is frequently developed in 
immunocompromised patients5,8,28.
CASE REPORT
Our patient is a previously healthy 37 year old male marine. He 
was on a military operation by the Putumayo River (Peruvian Amazon) 
for the last four months. He also cooked for the brigade, drank stream 
water, ate undercooked meat and had three cats. He specified that the 
brigade hunted mostly mammals (tapirs, peccaries) and ate fish. This 
patient was hospitalized in Iquitos because of pain in the right hip, with 
limping. He was prescribed pain relievers and rest. During the fifth day 
of hospitalization he developed fever,  dyspnea and decreased visual 
acuity. He was referred to the Peruvian Navy Hospital (Lima, Peru). 
Clinical examination revealed tachypnea, mild jaundice, left palpebral 
ptosis, rales in the two lower thirds of the left hemithorax. There was 
no adenopathy. His white cell count was 20,900 cells/µL (granulocytes 
83%, 4% rods, lymphocytes 10%), direct bilirrubin 1.41 mg/dL, alanine 
aminotransferase (ALT) 168U/L, aspartate aminotransferase (AST) 335 
U/L. Chest X ray showed a diffuse interstitial infiltrate. Chest computed 
tomography (CT) showed multiple nodular cavities and pleural effusion. 
(Fig. 1) Bronchoalveolar lavage (BAL) showed gram positive cocci 
but culture grew panresistant Pseudomonas aeruginosa. No other 
bacteria, fungi or acid fast bacilli were cultured either from sputum, 
BAL, thoracocentesis or blood samples. No bacteria were isolated 
with Ziehl Neelsen stain. The left fundoscopic examination revealed 
Fig. 1 - Chest CT scan: Nodular lesion and cavity in the right hemithorax and left pleural 
effusion. 
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a foggy pattern in the medial inferior macula and retinal hemorrhage. 
This finding was identified as Toxoplasma retinochoroiditis. Repeated 
serological testing for rheumatoid factor, ANCA, HIV, leptospirosis, 
aspergillus, hystoplasmosis, HTLV I - II, Cytomegalovirus, Epstein 
Barr Virus, Hepatitis B virus and thick blood smear for malaria were 
repeatedly negative. Treatment with Ceftriaxone, Clarithromycin plus 
Cothrimoxazol and Clindamicyn were started but the former two were 
changed on the 5th day for Imipenem and Vancomycin. However his 
fever, dyspnea and dry cough persisted. On the 15th day of his hospital 
stay, T. gondii serology results were received: IgG 40.8 UI/mL; IgM 1.4 
UI/mL (positive if: IgM ≥ 1.0 UI/mL; IgG ≥1.0 UI/mL). A thick blood 
smear showed tachyzoites of T. gondii (+++) (Fig 2). Sulfadoxine plus 
Pyrimethamine (Fansidar®) were started. Clindamycin and Cothrimoxazol 
were discontinued. Patient became afebrile on the second day of this 
treatment. Right hip MRI showed avascular necrosis and mild synovial 
effusion. Right hip biopsy showed T. gondii bradyzoites (Fig. 3, Fig. 4). 
Ig E levels were increased over six months (IgE: 2000 UI/mL). T. gondii 
PCR-based assay and IgM titers in blood samples were negative one year 
after treatment (Fig. 5). The patient only achieved partial recovery from 
his chorioretinitis and right hip disability.
DISCUSSION
Consumption of stream water contaminated by oocysts and game 
meat are the most important risk factors contributing to the predominance 
of T. gondii wild cycle, especially in French Guyana6. Presence of 
felines or other infected animals are the main risk factors for food and 
water contamination35. Isolation of an atypical T. gondii strain in a wild 
jaguar supports the existence of a T. gondii wild cycle in the Amazon11. 
Waterborne outbreaks due to contamination with T. gondii oocysts have 
also been described1,4. Moreover, this type of transmission is associated 
with more severe clinical outcomes22. 
On the other hand, people that participate in military operations do 
so under poor sanitary conditions and are exposed to biological factors 
in the new tropical environment10. Infection is the result of poor host 
adaptation to new strains. Thus, people who have been recently exposed 
to virgin forest are prone to developing the severe form of the disease. 
Fig. 2 - Tachyzoites are observed on thick blood smear. 100x
Fig. 3 - Right hip biopsy: hyaline degeneration of striated muscle fibers, absence of grooves 
and presence of multiple T. gondii cysts. (Arrows) PAS stain. 40x
Fig. 4 - Right hip biopsy: increased volume of muscle fibers due to hyaline degeneration 
and edema. Cyst containing multiple bradyzoites is shown in the center of the picture. PAS 
stain, 100x
Fig. 5 - Serological follow-up: IgM and IgG in T. gondii reinfection.
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However, our patient was the only case reported from that brigade. His 
main risk factor was cooking and manipulating game meat. Thus, he 
developed a wildlife cycle. Unfortunately, since he was in the jungle for 
a military operation and frequently exposed to risk factors, it is difficult 
for us to determine the incubation period.
T. gondii strains from South America have atypical genotypes and 
higher diversity compared to the ones formerly described in North 
America and Europe. These atypical strains have been associated with 
a worse clinical involvement and outcome in mice and humans7,25,32. 
Cases of severe toxoplasmosis in immunocompetent patients reported 
in French Guyana, Brazil and Surinam suggest that atypical strains of 
T. gondii might induce an increased pathogenicity5,24. Severe cases of 
toxoplasmosis have been previously reported in French Guyana, Surinam 
and Brazil5,11,24. Patients commonly develop a generalized infectious 
syndrome with visceral involvement such as mild hepatitis, jaundice, 
atypical pneumonia, enlarged lymph nodes and less frequently, myositis 
and chorioretinitis5,14. Our patient developed an atypical pneumonia with 
cavities and pleural effusion. However, interstitial pneumonia is the most 
frequent pulmonary manifestation5,9,24,34.
Even though Pseudomonas aeruginosa is a cause of necrotizing 
pneumonia, its isolation in this case is due to contamination. First, some 
reports describe hospital pseudo-outbreaks of P. aeruginosa pneumonia 
linked to the use of ventilators and other related instruments12,36. Second, 
sputum and blood culture results were negative on different occasions. 
Finally, despite panresistant Pseudomonas not having been related to an 
increased mortality18 our patient showed clinical improvement only after 
his second day of first line antiprotozoal therapy. 
Ocular toxoplasmosis is the most common cause of posterior uveitis 
in immunocompetent subjects. The lesions reported in our case are 
classified as severe and are mostly caused by T. gondii serotype I, which is 
less sensitive to therapy with Pyrimethamin in vitro3,20,33. Musculoskeletal 
involvement concomitant to T. gondii infection in immunocompetent 
patients is described as a proximal and symmetrical myositis29-31; in 
contrast to the focal and asymmetrical involvement (right thigh) reported 
hereby. Although trauma is a frequent cause of avascular necrosis, the 
antiangiogenic state triggered by T. gondii impairs healing and is an 
aggravating factor for this condition21,38. Slow and partial recovery from 
right hip articulation disability can also be explained by axonolysis, and 
an altered immune response38. Relapses have been reported even after 
receiving first line antiprotozoal treatment, because it does not eliminate 
bradyzoites and in other cases because of long corticosteroid therapy29. 
Toxoplasmosis is very frequent in South America; indeed 84% of 
the inhabitants of the Peruvian Amazon are infected. Even though we 
do not have a baseline serology for our patient we treated this clinical 
scenario as if it were a reinfection by T. gondii. Our patient’s IgM, IgG 
and IgE curves during his hospitalization support our diagnosis17,28. In 
2006, DZITKO et al. describe slightly increased IgM and moderately 
increased IgG levels after inoculating a virulent strain to chronically 
infected mice15. In other words, as our patient was previously exposed, 
his IgM levels did not increase as much as his IgG levels. It is also known 
that T. gondii is an intracellular parasite that induces a humoral response. 
In this way, IgE plays a fundamental role in antibody-dependent cellular 
cytotoxicity (ADCC). IgE levels are increased during the first five months 
following infection. It has a high specificity (91.7%) for acute T. gondii 
infection when measured with other markers of infection (IgG) and has 
the best association with clinical findings23,27.
Diagnosis of T. gondii re-infection in this case is based on T. gondii 
isolation on thick blood smear and hip biopsy, serology results, typical 
retinochoroiditis and effective antiprotozoal treatment in the absence 
of the most common causes of infectious syndrome with visceral 
involvement and immunodeficiency. 
Hereby, this is the first time a severe case of disseminated 
toxoplasmosis in an immunocompetent adult from Peru is reported. 
Even though toxoplasmosis is not the most common cause of pneumonia 
in Peru, we recommend keeping it as a differential diagnosis in people 
coming from endemic areas like the Amazon, especially military recruits. 
Due to constant human migration to our tropical rainforest it is also 
important to identify risk population.
We hypothesize that T. gondii serotypes from the Peruvian Amazon 
could share the same atypical strains and disease patterns as the ones 
found in Brazil and French Guyana. We encourage further research on 
Amazonian T. gondii wild cycle, in this way we would improve knowledge 
of its distribution, disease patterns and prevention in the Amazon Basin. 
RESUMEN
Toxoplasmosis diseminada en un paciente inmunocompetente 
procedente de la Amazonía peruana
Reportamos un caso de toxoplasmosis severa en un paciente 
inmunocompetente caracterizado por neumonía, retinocoroiditis, hepatitis 
y miositis. El diagnóstico fue confirmado por serología, el hallazgo de T. 
gondii en gota gruesa y la presencia de bradizoitos en biopsia muscular. 
El tratamiento con pirimetamina mas sulfadoxina fue exitoso pero solo 
hubo una parcial recuperación de la agudeza visual y de la capacidad 
de extensión de la cadera. Este es el primer reporte de un caso de 
toxoplasmosis severa en el Perú. 
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